Shaminul H Shakib,Demetra Antimisiaris
Shaminul H Shakib
Background: Increased diagnoses burden is a characteristic of post COVID sequelae. Concomitant increased polypharmacy burden is a consequence yet there are few publications on the topic. The aim of this report is to help ...
Vincenzo Giosuè Giambusso,Martina Rafanelli,Robert S Sheldon
Vincenzo Giosuè Giambusso
Introduction: Vasovagal syncope is a frequent problem affecting nearly half the population. The symptom burden is wide, ranging from once to hundreds of times. It reduces quality of life and causes injuries. Physicians, p...
The continuing search for effective treatments for older adults with acute myeloid leukemia [0.03%]
不断寻找有效治疗急性髓系白血病老年人的方法
Xavier Thomas
Xavier Thomas
Introduction: The goal of treatment in older patients (≥60 years) with acute myeloid leukemia (AML) has recently switched from only improving quality of life to achieving long-term survival via prolonged therapy. Novel t...
Aleksandra Kovačević,Aneta V Perić,Aleksandar Perić
Aleksandra Kovačević
Introduction: Pediatric chronic rhinosinusitis (CRS) is a heterogeneous inflammatory disease with multifactorial etiology. CRS is less prevalent in children than in adults, but it substantially affects the patient's quali...
Optimizing anticholinergic use in urology: strategies for safe prescribing amidst polypharmacy [0.03%]
泌尿科抗胆碱药的优化使用：多药共用情况下的安全用药策略
Pragnitha Chitteti,Sophie Nicholson,Mehwash Nadeem
Pragnitha Chitteti
Comparison of dopamine D2 receptor occupancy profiles between risperidone ism versus oral risperidone and monthly paliperidone palmitate based on population pharmacokinetic modelling and simulations [0.03%]
利培酮长效微球与口服利培酮和一个月一次的帕利哌酮酯在多动症D2受体占有率方面的比较：基于人群药代动力学模型及模拟研究
Eric Snoeck,Nicolas Luyckx,Andreas Lindauer et al.
Eric Snoeck et al.
Background: Risperidone-ISM® does not require loading dose or oral supplementation. Dopamine D2 Receptor Occupancy (D2RO) profiles between Risperidone-ISM® versus oral risperidone (OR) and monthly-paliperidone palmitate...
Theodoros Panou,Evanthia Gouveri,Djordje S Popovic et al.
Theodoros Panou et al.
Introduction: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used in the management of type 2 diabetes mellitus (T2DM) and obesity. Areas...
Botulinum toxin in focus: evolution, pharmacology, and it's expanding clinical impact [0.03%]
肉毒杆菌毒素的研究热点：发展、药理及临床影响的扩展
Hira Bakhtiar Khan,Pragnitha Chitteti,Mehwash Nadeem
Hira Bakhtiar Khan
Introduction: Botulinum toxin (BoNT), recognized for its distinctive pharmacological properties, has become a highly effective therapeutic agent with a wide range of clinical applications. Among its serotypes, botulinum t...
PREG-ADR: development and validation of a predictive tool for adverse drug reactions in hospitalized pregnant women [0.03%]
PREG-ADR：一种预测和验证住院孕妇不良药物反应的预测工具的发展
Priscilla Karilline Do Vale Bezerra,Larissa Cândido Gomes da Silva,Hilris Rocha E Silva et al.
Priscilla Karilline Do Vale Bezerra et al.
Background: Adverse drug reactions (ADRs) in hospitalized pregnant women remain under-recognized, and no validated risk prediction tools are currently available. We developed and validated a tool to estimate individual AD...
Alessandro Rizzo,Enes Erul,Deniz Can Guven et al.
Alessandro Rizzo et al.
Introduction: Biliary tract cancer (BTC) is an aggressive cancer arising from biliary epithelial cells. The combination of immune checkpoint inhibitors (ICIs) with other anticancer therapies has recently emerged as a new ...